Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4743 is a small, non-coding RNA molecule from the microRNA family, expressed in humans as hsa-mir-4743. Like other microRNAs, it is involved in regulating gene expression post-transcriptionally, usually by binding to complementary sequences on target mRNAs, resulting in translational repression or mRNA degradation. Its dysregulation (notably the 5p strand, hsa-miR-4743-5p) has been observed in patients with type 2 diabetes and coronary artery disease, suggesting a biomarker role and possible involvement in the molecular pathways influencing vascular function, metabolism, and cellular adhesion. A broader functional context suggests that MIR4743, through its target genes, may participate in cellular signaling, calcium ion binding, cytoskeletal organization, and several signal transduction pathways relevant to disease processes. However, it is not currently a direct drug target, and research is ongoing to clarify its specific roles and downstream effects in human health and disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4743 (MIR4743).